1336 related articles for article (PubMed ID: 25027057)
1. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin in children admitted to hospital with community acquired pneumonia.
Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
[TBL] [Abstract][Full Text] [Related]
5. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?
Korppi M
Pediatr Int; 2004 Oct; 46(5):545-50. PubMed ID: 15491381
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of the semiquantitative procalcitonin test in the diagnosis of bacterial infections in a third level children's hospital.
Rustici MC; Chiappini E; Salvadori M; Sollai S; Galli L; de Martino M
Clin Lab; 2011; 57(7-8):497-506. PubMed ID: 21888013
[TBL] [Abstract][Full Text] [Related]
7. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
[TBL] [Abstract][Full Text] [Related]
8. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis.
Yang AP; Liu J; Yue LH; Wang HQ; Yang WJ; Yang GH
Clin Chem Lab Med; 2016 Feb; 54(2):345-51. PubMed ID: 26351925
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
12. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
[TBL] [Abstract][Full Text] [Related]
14. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.
Bhuiyan MU; Blyth CC; West R; Lang J; Rahman T; Granland C; de Gier C; Borland ML; Thornton RB; Kirkham LS; Martin A; Richmond PC; Smith DW; Jaffe A; Snelling TL
BMC Pulm Med; 2019 Apr; 19(1):71. PubMed ID: 30940126
[TBL] [Abstract][Full Text] [Related]
15. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
16. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection.
Prat C; Domínguez J; Rodrigo C; Giménez M; Azuara M; Jiménez O; Galí N; Ausina V
Pediatr Infect Dis J; 2003 Nov; 22(11):963-8. PubMed ID: 14614368
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin levels predict infectious complications and response to treatment in patients undergoing cytoreductive surgery for peritoneal malignancy.
Saeed K; Dale AP; Leung E; Cusack T; Mohamed F; Lockyer G; Arnaudov S; Wade A; Moran B; Lewis G; Dryden M; Cecil T; Cepeda JA
Eur J Surg Oncol; 2016 Feb; 42(2):234-43. PubMed ID: 26560024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
